Craig Basson

Craig Basson, MD, PhD

Chief Medical Officer

Dr. Craig T. Basson is the Chief Medical Officer at Bitterroot Bio. A veteran of the pharmaceutical and biotechnology industries, as well as academia, Dr. Basson spent a decade at Novartis, where he was Global Head of Translational Medicine for the Cardiovascular and Metabolic Therapeutic Areas. In 2020, he joined Boston Pharmaceuticals as the Chief Medical Officer, where he led a broad pipeline of molecules in general medicine and oncology before serving as interim Co-Chief Executive Officer. Prior to joining the biotechnology industry, Dr. Basson was the Harriman Professor of Cardiology and Internal Medicine and Director of Cardiovascular Research at Cornell University Medical College, where he led the Greenberg Center for Molecular Cardiology.

Dr. Basson holds a BA and MA in biology from Washington University, St. Louis, and earned an MSc in physiological sciences from the University of Oxford, where he was a Marshall Scholar. He then went on to earn an MD and PhD from Yale University. Dr. Basson completed his residency in internal medicine at Johns Hopkins Hospital and his clinical cardiology fellowship and cardiovascular genetics postdoctoral fellowship at Harvard University and the Brigham and Women’s Hospital.

Bitterroot Bio is a privately held company dedicated to the pursuit of breakthroughs in cardiovascular medicine. We are committed to improving the lives of patients, and we believe that focusing on research and development is the best way to achieve that goal. We do not engage in, support, or advocate on behalf of political, social, environmental, or other causes that are unrelated to our mission.
Scroll to Top